TAUNS Laboratories, Inc.
197A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | ¥54,736 | ¥44,597 | ¥41,900 | ¥41,900 |
| - Cash | ¥9,267 | ¥9,425 | ¥1,244 | ¥6,347 |
| + Debt | ¥14,424 | ¥9,539 | ¥6,468 | ¥4,900 |
| Enterprise Value | ¥59,894 | ¥44,711 | ¥47,124 | ¥40,453 |
| Revenue | ¥18,628 | ¥18,435 | ¥15,673 | ¥17,457 |
| % Growth | 1% | 17.6% | -10.2% | – |
| Gross Profit | ¥12,326 | ¥12,498 | ¥8,786 | ¥14,287 |
| % Margin | 66.2% | 67.8% | 56.1% | 81.8% |
| EBITDA | ¥9,020 | ¥8,646 | ¥5,317 | ¥8,551 |
| % Margin | 48.4% | 46.9% | 33.9% | 49% |
| Net Income | ¥6,315 | ¥5,774 | ¥3,035 | ¥4,481 |
| % Margin | 33.9% | 31.3% | 19.4% | 25.7% |
| EPS Diluted | 58.9 | 57.74 | 30.35 | 44.81 |
| % Growth | 2% | 90.2% | -32.3% | – |
| Operating Cash Flow | ¥6,818 | ¥9,935 | -¥3,158 | ¥10,695 |
| Capital Expenditures | -¥4,681 | -¥3,961 | -¥1,166 | -¥2,300 |
| Free Cash Flow | ¥2,137 | ¥5,974 | -¥4,323 | ¥8,395 |